Company Cybin Inc.

Equities

CYBN

CA23256X1006

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 12:34:41 2024-05-20 pm EDT 5-day change 1st Jan Change
0.348 USD -0.57% Intraday chart for Cybin Inc. +1.02% -15.27%

Business Summary

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

Number of employees: 50

Managers

Managers TitleAgeSince
Chief Executive Officer 54 20-07-31
Founder 35 16-10-12
Founder 49 16-10-12
Director of Finance/CFO 54 20-11-04
Chief Tech/Sci/R&D Officer 64 20-11-30
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 21-09-30
Chief Tech/Sci/R&D Officer - 20-09-30
Chief Administrative Officer - -
Chief Operating Officer - 20-11-30

Members of the board

Members of the board TitleAgeSince
Founder 49 16-10-12
Director/Board Member 52 20-11-04
Director/Board Member 62 20-11-04
Director/Board Member - 21-08-15
Director/Board Member 43 23-10-22
Director/Board Member 63 20-11-04
Founder 35 16-10-12

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 759,692,495 709,079,609 ( 93.34 %) 0 93.34 %

Shareholders

NameEquities%Valuation
Deep Track Capital LP
7.653 %
58,139,535 7.653 % 20 M $
RA Capital Management LP
7.653 %
58,139,535 7.653 % 20 M $
RA Capital Management LP
7.653 %
58,139,535 7.653 % 20 M $
Deep Track Capital LP
7.653 %
58,139,535 7.653 % 20 M $
Logos Global Management LP
5.265 %
40,000,000 5.265 % 14 M $
Avidity Partners Management LP
4.592 %
34,884,000 4.592 % 12 M $
Point72 Asset Management LP
3.957 %
30,061,112 3.957 % 10 M $
Sphera Funds Management Ltd.
3.367 %
25,581,395 3.367 % 9 M $
Octagon Capital Advisors LP
2.449 %
18,604,650 2.449 % 6 M $
16,593,494 2.184 % 6 M $
NameEquities%Valuation
144,353 14.35 % 49 946 $

Company contact information

Cybin, Inc.

100 King Street West Suite 5600

M5X 1C9, Toronto

+

http://www.cybin.com
address Cybin Inc.(CYBN)
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW